Research News for February 26, 2020
advertisement
- Regular thyroid testing recommended regardless of diabetes type
- Distinct Growth Phases in Early Life Associated With the Risk of Type 1 Diabetes: The TEDDY Study
- A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial
- Rediscovery of the Second β-Cell Hormone: Co-replacement With Pramlintide and Insulin in Type 1 Diabetes. (HTML)
- Beta cells with ‘super powers’ hold potential for improved diabetes care
- Association between reduced serum levels of magnesium and the presence of poor glycemic control and complications in type 1 diabetes mellitus: A systematic review and meta-analysis. (HTML)
- Type 1 diabetes progression is associated with loss of CD3+CD56+ regulatory T cells that control CD8+ T-cell effector functions
- Biogenic integrated ZnO/Ag nanocomposite: Surface analysis and in vivo practices for the management of type 1 diabetes complications. (HTML)
- Immune Intervention in Type 1 Diabetes. (HTML)
- Targeting proinsulin to local immune cells using an intradermal microneedle delivery system; a potential antigen-specific immunotherapy for type 1 diabetes. (HTML)
- A Pilot Study of Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion (CSII) in Adults with Type 1 Diabetes (FIRST1D). (HTML)
- Lipid signaling from beta cells linked to inflammatory macrophage polarization
- The prevalence of microvascular complications in Waikato children and youth with type 1 diabetes has reduced since 2003.
- A step towards precision medicine for the management of monogenic diabetes
- Benchmarking machine learning algorithms on blood glucose prediction for Type 1 Diabetes in comparison with classical time-series models. (HTML)
- Incidence of fractures in patients with type 1 diabetes mellitus-a retrospective study with 4420 patients. (HTML)
- The relationship between glycaemic variability and cardiovascular autonomic dysfunction in patients with type 1 diabetes: a systematic review. (HTML)
- Use of more expensive insulin despite guidelines in Brazil. (HTML)
